Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.
PolandPhase 2 Study of Rinatabart Sesutecan with PEGFILGRASTIM in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PolandA study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma
PolandA study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes
PolandA study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis
PolandComparing Sotorasib and Pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
PolandA study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines
PolandA study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.
PolandA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
PolandA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
PolandA study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer
PolandStudy of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
